Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 2,901–2,925 of 7,816 matching trials · page 117 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
The Skin as a Window to the Central Nervous System in Frontotempolar Lombar Degeneration NCT06490822 Skin biopsy Runs in: France · 1 site |
NA other |
RECRUITING | 80 | Nantes University Hospital OTHER |
2024-12-20 |
|
The Hospice Advanced Dementia Symptom Management and Quality of Life Trial (HAS-QOL) NCT04175977 Aliviado Dementia Care-Hospice Edition QAPI program; Usual Care Runs in: United States · 1 site |
NA other |
COMPLETED | 44,143 | NYU Langone Health OTHER |
2024-12-19 |
|
tDCS and Cognitive Efficiency in Ageing NCT05216315 Transcranial direct current stimulation (tDCS); Sham stimulation Runs in: Spain · 1 site |
NA other |
COMPLETED | 38 | University of Valencia OTHER |
2024-12-19 |
|
A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003. NCT05345509 Aricept Tablet; IVL3003; IVL3003 Runs in: Australia · 1 site |
PHASE1|PHASE2 other |
ACTIVE_NOT_RECRUITING | 62 | Inventage Lab., Inc. INDUSTRY |
2024-12-19 |
|
Cohort of Patients with Alzheimer's Disease and Their Families. NCT05516667 Runs in: France · 4 sites |
NA other |
RECRUITING | 1,000 | University Hospital, Toulouse OTHER |
2024-12-19 |
|
Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer NCT01945762 Vandetanib 300 mg Runs in: Belgium; France; Germany; Italy; Luxembourg; Netherlands;... · 8 sites |
NA other |
COMPLETED | 31 | Genzyme, a Sanofi Company INDUSTRY |
2024-12-18 |
|
Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration NCT02964611 Observational Study Runs in: Canada · 1 site |
NA other |
COMPLETED | 120 | University Health Network, Toronto OTHER |
2024-12-18 |
|
Families Coping Together With Alzheimer's Disease NCT04642885 Runs in: United States · 1 site |
NA other |
COMPLETED | 354 | Yale University OTHER |
2024-12-18 |
|
Long-term Effect of TMS in Primary Progressive Aphasia NCT05842473 Transcranial Magnetic Stimulation (active); Language therapy; Trans... Runs in: Spain · 1 site |
NA other |
COMPLETED | 63 | Hospital San Carlos, Madrid OTHER |
2024-12-18 |
|
Interest of the Reborn® Doll as a TO in the Care of Residents With Alzheimer's Disease or a Related Disorder NCT06396377 Reborn doll (Therapeutic object - OT) Runs in: France · 1 site |
NA other |
COMPLETED | 24 | University Hospital, Clermont-Ferrand OTHER |
2024-12-18 |
|
A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003) NCT06586606 MK-1708; Itraconazole Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 12 | Merck Sharp & Dohme LLC INDUSTRY |
2024-12-18 |
|
Effectiveness of Dementia Nutrition Education NCT06739642 Education Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 89 | Manisa Celal Bayar University OTHER |
2024-12-18 |
|
MEDical CANnabis for Improving Symptoms During Severe DEMentia Disorders in Long-term Care Facility in Geneva NCT05432206 Cannabis Sativa Oil; Placebo Runs in: Switzerland · 1 site |
PHASE2|PHASE3 other |
COMPLETED | 27 | Fondation pour l'accueil et l'hébérement des personnes âgées OTHER |
2024-12-17 |
|
BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers NCT05457998 Flutemetamol F18 Injection; [18F]-RO6958948 Injection; [18F]-MK-624... Runs in: United States · 1 site |
NA other |
ENROLLING_BY_INVITATION | 200 | Butler Hospital OTHER |
2024-12-17 |
|
Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter Disease NCT02330510 Runs in: Canada · 8 sites |
NA other |
COMPLETED | 80 | Dr. Sandra E Black OTHER |
2024-12-16 |
|
Proteinopathies Expression in Skin of Neurodegenerative Disorders NCT06528964 Immunohistochemistry and immunofluorescence Runs in: Mexico · 1 site |
NA other |
RECRUITING | 40 | Universidad Autonoma de San Luis Potosí OTHER |
2024-12-16 |
|
Transcranial Pulse Stimulation. a Potential Treatment for Early Dementia NCT06730438 Transcranial Pulse Stimulation Runs in: Italy · 2 sites |
NA other |
RECRUITING | 100 | Francesca Pistoia OTHER |
2024-12-16 |
|
Working Memory Training in Patients with Mild Cognitive Impairment NCT06734286 CogMed Runs in: United States · 1 site |
NA other |
RECRUITING | 10 | St. Joseph's Hospital and Medical Center, Phoenix OTHER |
2024-12-16 |
|
Effect of Vırtual Realıty Glasses on Mıld Cognıtıve Impaırment in Elderly NCT06735352 virtual reality intervention Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 12 | Karadeniz Technical University OTHER |
2024-12-16 |
|
[C-11]PiB PET Imaging in Alcohol Use Disorders NCT03746366 [C-11]; Pittsburgh Compound B Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 39 | University of Pittsburgh OTHER |
2024-12-13 |
|
Self-management and HeAlth Promotion in Early-stage Dementia With E-learning for Carers NCT04286139 SHAPE Runs in: Australia; Norway; United Kingdom · 5 sites |
NA other |
COMPLETED | 210 | Helse Stavanger HF OTHER_GOV |
2024-12-13 |
|
Reducing Racism and Discrimination in Schools: Comprehensive Prevention Services NCT05189769 CP no REACT; CP+/No REACT; CP and REACT; CP+ and REACT Runs in: United States · 2 sites |
NA other |
ACTIVE_NOT_RECRUITING | 1,093 | University of Alabama, Tuscaloosa OTHER |
2024-12-13 |
|
MAD Study of NX210c NCT05827653 NX210c; Placebo Runs in: Netherlands · 1 site |
PHASE1 other |
COMPLETED | 29 | Axoltis Pharma INDUSTRY |
2024-12-13 |
|
Comprehensive Cognitive and Affective Intervention for Mild Cognitive Impairment (MCI) for Foreign-Born Arab Americans NCT05854290 CRT; CBT; Modifiable lifestyle factors; Usual care Psychoeducation Runs in: United States · 1 site |
NA other |
TERMINATED | 1 | University of Michigan OTHER |
2024-12-13 |
|
Nature-based Virtual Reality Intervention for Depression in Alzheimer's Disease NCT06732128 nature-based virtual reality applications and videos; nature-based videos Runs in: Canada · 1 site |
NA other |
RECRUITING | 50 | Centre for Addiction and Mental Health OTHER |
2024-12-13 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial